GenBio AI is an AI company headquartered in Silicon Valley with hubs in Paris and the UAE that is developing a new way to understand and program human biology. The company is building AIDO, the AI-Driven Digital Organism, to address a fundamental limitation in traditional biomedical research. Today, most research analyzes DNA, RNA, proteins, cells, and tissues separately. Biology does not function in separate parts. It operates as an interconnected system. GenBio AI aims to d

Bayan A. Alturkestani, founder and CEO of Conan MedTech had her “Aha!” moment while working on testing a potential drug for treating mild Traumatic Brain Injury also known as concussion and studying its effect on motor function in 2019: What would be the point, she wondered, in developing drugs to immediately treat concussion victims, if the concussions cannot be immediately diagnosed? Eventually this experience led to her decision to start working on developing a diagnostic

The story of Lenoss Medical begins with CEO and President, Dom Messerli, a spine industry veteran with 30 years of experience at large medical device corporations, thinking there must be a better way of repairing vertebral compression fractures due to Osteoporosis. Osteoporosis can quietly weaken your bones over time-especially the ones in your spine called vertebrae. When these bones become too fragile, they can collapse resulting in a vertebral compression fracture, or VCF

Azalea Vision is redefining how to correct, manage, and interact with health and vision. Born as a spin-off from imec and Ghent University, Azalea Vision is developing the first medical-grade smart lens platform that adapts, connects, and responds in real time—bringing a new level of intelligence to ophthalmic care. Azalea’s lens-embedded system combines adaptive optics, embedded microelectronics, and NFC connectivity to deliver both therapeutic and diagnostic functions wit